The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s cell and gene therapy manufacturing services market report forecasts the cell and gene therapy manufacturing services market size to grow to $13.50 Billion by 2027, with a CAGR (compound annual growth rate) of more than 16%.

Learn More On The Cell And Gene Therapy Manufacturing Services Market Report 2023 – https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-manufacturing-services-global-market-report

Cell And Gene Therapy Manufacturing Services Market Size Forecast
The global cell and gene therapy manufacturing services market is expected to grow from $5.85 billion in 2022 to $7.25 billion in 2023 at a compound annual growth rate (CAGR) of 23.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global cell & gene therapy manufacturing services market size is expected to reach $13.50 billion in 2027 at a CAGR of 16.81%.

North America held the largest cell and gene therapy manufacturing services market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Cell And Gene Therapy Manufacturing Services Market Driver ­– Rise In The Incidence Of Cancer And Other Target Diseases
For example, according to a data provided by the National Cancer Institute, a US-based government institution, a predicted 1,806,590 new cancer cases were discovered in the US in September 2020, while 606,520 people died from the illness. In 2020, 1,730 cancer-related fatalities and 16,850 new cancer diagnoses among children and teenagers aged 0 to 19 are expected. It is expected that 29.5 million new cases of cancer would be diagnosed each year by 2040, with 16.4 million people dying from the disease. Furthermore, the American Cancer Society reported that the expected number of new cancer cases in 2021 was 1,898,160, which grew to 1,918,030 in 2022.As a result, the rising prevalence of cancer and other target diseases is propelling the cell and gene therapy manufacturing services market ahead.

Request for A Sample Of The Global Cell And Gene Therapy Manufacturing Services Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10035&type=smp

Key Cell And Gene Therapy Manufacturing Services Market Trend – Technological Advancement
To maintain their market position, major firms in the cell and gene therapy manufacturing services industry are implementing new technologies. Charles River Laboratories International Inc., a US-based pharmaceutical firm specialising in different preclinical and clinical laboratory, gene therapy, and cell therapy services, for example, launched the navigationTM Vector Platform (navigation) in October 2022. It is a platform that streamlines the road to GMP Adeno-Associated Virus (AAV) vector manufacture while avoiding the need for substantial process development. The navigation platform can reduce a program’s time to GMP by 55% as compared to typical production workflows for viral vector gene therapy researchers. The navigation technique used by Charles River is based on a unique high-productivity HEK293 suspension cell line that can be scaled up and serotyped to match the needs of clients.

Cell And Gene Therapy Manufacturing Services Market Segment
1) By Type: Gene Therapy, Cell Therapy
2) By Indication: Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopaedic Diseases, Oncology Diseases
3) By Application: Commercial Manufacturing, Clinical Manufacturing
4) By End-user: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Cell And Gene Therapy Manufacturing Services Market Major Players and Strategies
Major players in the cell and gene therapy manufacturing services market are Thermo fisher scientific inc., Merck KGaA, Charles River Laboratories International Inc., Lonza Group AG, Catalent Inc., WuXi AppTec, Takara bio inc., Nikon corporation, Fujifilm Holdings Corporation, F. Hoffmann-la roche ltd., Oxford Biomedica, CGT Catapult, Bluebird bio, Inc., Boehringer Ingelheim International GmbH, and Innovative Cellular Therapeutics Co. Ltd.

Thermo Fisher Scientific Inc, a US-based provider of scientific instrumentation, reagents, consumables, and software services, paid $880 million in cash to buy Henogen SA in January 2021. Thermo Fisher’s global capacity for cell and gene therapies would be expanded as a result of the acquisition. In the viral vector industry, it is constantly improving its capabilities for cell and gene vaccines and medicines around the world. Henogens’ laboratory products and services division would be absorbed into Thermo Fisher’s Pharma Services division. Henogen SA is a biomanufacturing firm established in Belgium that offers development and manufacturing services.

The Cell And Gene Therapy Manufacturing Services Global Market Report 2023 covers regional data on cell and gene therapy manufacturing services market size, cell and gene therapy manufacturing services market trends and drivers, opportunities, strategies, and cell and gene therapy manufacturing services market competitor analysis. The countries covered in the cell and gene therapy manufacturing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Cell and gene therapy manufacturing services include the production and testing of gene and cell therapy products. It contributes to the development and manufacture of treatments for degenerative diseases, tissue damage, and genetic anomalies. Good manufacturing practises, supplementary reagents, flow cytometry, immunoassays, and gene engineering services are among the services provided.

View More Reports Related To The Cell And Gene Therapy Manufacturing Services Market –
Gene Therapy Global Market Report 2023
Cell And Gene Therapy Global Market Report 2023
Cell Therapy Technologies Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: